Future of antifungal and antiviral agents. 2. Antiviral agents. b. Present status of chemotherapy of viral infections of the respiratory tract
Togo, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 42(3): 645-650
1984
ISSN/ISBN: 0047-1852 PMID: 6206255 Document Number: 225976
Document emailed within 1 workday
Related Documents
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924Wu, E.; Grado, C. 1988: Antiviral agents in viral respiratory infections Revista Chilena de Pediatria 59(3): 192-199
Loginova, S.I.; Borisevich, S.V.; Maksimov, V.A.; Bondarev, V.P. 2009: Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections Antibiotiki i Khimioterapiia 54(3-4): 11-14
Krylova, N.V.; Popov, A.M.; Leonova, G.N. 2016: Antioxidants as Potential Antiviral Agents for Flavivirus Infections Antibiotiki i Khimioterapiia 61(5-6): 25-31
Suresh, L.; Radfar, L. 2003: Antifungal and antiviral chemotherapy Alpha Omegan 96(4): 35-40
Bukhari, E.E.; Elhazmi, M.M. 2013: Viral agents causing acute lower respiratory tract infections in hospitalized children at a tertiary care center in Saudi Arabia Saudi Medical Journal 34(11): 1151-1155
Vlietinck, A.J.; Vanden Berghe, D.A.; Haemers, A. 1988: Present status and prospects of flavonoids as anti-viral agents Progress in Clinical and Biological Research 280: 283-299
Broniarek, E. 1994: Immunologic processes in human placenta and their role in antiviral resistance. I. Virus infections of the uterus. Nonspecific antiviral immunity Postepy Higieny i Medycyny Doswiadczalnej 48(3): 227-241
Ablordeppey, S.Y.; Fan, P.; Ablordeppey, J.H.; Mardenborough, L. 1999: Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development Current Medicinal Chemistry 6(12): 1151-1195
Il'inskaia, O.N.; Shakh Makhmud, R. 2014: Ribonucleases as antiviral agents Molekuliarnaia Biologiia 48(5): 707-717
Miki, M.; Watanabe, A. 2012: New antiviral agents of influenza Nihon Rinsho. Japanese Journal of Clinical Medicine 70(4): 649-654
Styrt, B.; Freiman, J.P. 1995: Hepatotoxicity of antiviral agents Gastroenterology Clinics of North America 24(4): 839-852
Oizumi, K. 1987: Refractory respiratory tract infections. 4. Selection of chemotherapeutic agents and their administration. c. Pseudomonas infections Nihon Rinsho. Japanese Journal of Clinical Medicine 45(3): 526-530
Benndorf, S.; Meyer, F.P.; Walther, H. 1975: Ambulatory treatment of virus-induced respiratory tract diseases. 4. Clinical aspects and therapy of virus-induced respiratory tract infections as well as the developmental aspects of antiviral therapy Zeitschrift für Arztliche Fortbildung 69(22): 1153-1162
Fabani, M.M.; Turner, J.J.; Gait, M.J. 2006: Oligonucleotide analogs as antiviral agents Current Opinion in Molecular Therapeutics 8(2): 108-114
Vesikari, T.; Paavonen, J. 2000: Antiviral agents and the practicing physician Duodecim; Laaketieteellinen Aikakauskirja 116(1): 27-36
Smith, D.W. 1992: Antiviral agents: problems and promises Medical Journal of Australia 157(2): 80-82
Beker, I. 1971: Rifamycin: progress in development of antiviral agents Harefuah 80(6): 336-338
Nash, E.; Benatar, S.; Abratt, R.; van Zyl Smit, R.; van Niekerk, J.P.; Meyerson, D.; Ress, S.; Kyriacos, U.; Sanders, H.R.; Stewart, C.; Peter, E. 1999: Use of antiviral agents in pregnant women with HIV infection South African Medical Journal 89(7): 704
Groeneveld, K.; van der Noordaa, J. 2005: Use of antiviral agents and other measures in an influenza pandemic Netherlands Journal of Medicine 63(9): 339-343